The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ensartinib as postoperative adjuvant therapy in patients with ALK-positive non-small cell lung cancer (NSCLC): A registered, retrospective, real-world study.
 
Lin Wang
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Sihua Wang
No Relationships to Disclose
 
Siyuan Dong
No Relationships to Disclose
 
Xiaoming Qiu
No Relationships to Disclose
 
Lei Zhao
No Relationships to Disclose
 
Zhongyuan Yin
No Relationships to Disclose
 
Kong-Jia Luo
No Relationships to Disclose
 
Changfa Qu
No Relationships to Disclose
 
Xiangning Fu
No Relationships to Disclose
 
Baogang Liu
No Relationships to Disclose
 
Junfeng Wang
No Relationships to Disclose
 
Yang Xue
No Relationships to Disclose
 
Sai Zhang
No Relationships to Disclose
 
Liang Yu
No Relationships to Disclose
 
Renhua Guo
No Relationships to Disclose
 
Jialong Guo
No Relationships to Disclose
 
Ruilin Song
No Relationships to Disclose
 
Lanjun Zhang
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose